Navigation Links
China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results
Date:4/23/2009

    CHANGCHUN, China and LOS ANGELES, April 23 /PRNewswire-Asia-FirstCall/ --

    - Fourth Quarter 2008 Revenue Increased 28.6% to $14.1 Million, with Net
      Income was $0.9 Million and Diluted EPS of $.03

    - 2008 Revenues Increased 23.5% to $59.1 Million vs. 2007

    - 2008 Gross Profit Margin Improved 340 Basis Points to 20.1%

    - 2008 Net Income Increased 13.7% to $4.1 Million with Diluted EPS of
      $0.13

    - 2008 Cash Flow from Operations was $5.9 million

China Yongxin Pharmaceuticals, Inc. ("China Yongxin Pharmaceuticals" or "the Company") (OTC Bulletin Board: CYXN), a leading manufacturer, distributor and retailer of pharmaceuticals in Northeastern China, today announced Annual 2008 financial results ended December 31, 2008.

Fourth Quarter Ending December 31, 2008 Financial Results

Yongxin announced record revenue for its fourth quarter of $14.1 million, representing a 28.6% increase from $11 million recorded in the fourth quarter of fiscal 2007. Growth was driven by increased sales from both its wholesale distribution and retail business segment.

Gross profit in the fourth quarter 2008 was $3.5 million, a 122.8% increase from $1.6 million in the fourth quarter of 2007. Gross margins were 24.6% in the fourth quarter of 2008, compared to 14.2% in the fourth quarter of 2007.

Operating expenses were approximately $2 million, representing a 112.6% increase from approximately $1 million in the fourth quarter of 2007, and were directly related to increased marketing and selling expenses. Income from operations was $1.4 million, an increase of 138.8% from $0.6 million in the same period of 2007. Operating margins were 10.1% compared to 5.4%.

Net income for the quarter was $0.9 million, down from net income of $1.3 million in the same period a year ago. Income taxes were approximately $346,053 and 0 representing an effective
'/>"/>

SOURCE China Yongxin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. China Breaks Ground on Largest Comprehensive Stem Cell Storage and Processing Facility
2. China-Biotics, Inc. Supplies Probiotics as Additive for Poultry Feed
3. HUYA Bioscience Announces Strategic Alliance With Abbott on Drug and Biomarker Development Candidates From China
4. China Biologic Products Completes Acquisition of 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.
5. China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results
6. China Sky One Medical, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2008 Results
7. NeoStem Completes $11 Million Private Placement Financing to Support Expansion Activities in China, Further Development of NeoStems VSEL Technology and Advancement of Medical Tourism Initiatives
8. China Sky One Medical, Inc. Provides Update on Filing Form 10-K
9. China Agri-Business Announces 2008 Operating Results
10. China Biologic Products Announces Strong 2008 Results
11. ACM Global Central Lab Announces Partnership with Chindexs United Family Hospitals in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... PARK, Calif. , July 24, 2014 ... seven-year contract with the National Institute of Allergy and ... Health, to conduct preclinical development of potential therapies for ... of drugs to treat HIV and AIDS and the ... well as microbicides for preventing sexual transmission of HIV. ...
(Date:7/24/2014)... 24, 2014 Three companies from the ... Livestrong’s Big C Competition. Out of 700 competition entrants, ... to the semi-final round. In this round twenty teams ... program, complete with mentoring from thought-leaders and medical entrepreneurs ... of the angelMD commitment to the Livestrong vision around ...
(Date:7/24/2014)... -- Neogen Corporation (Nasdaq: NEOG ) advised market ... from new rodenticide research are premature. In its regular ... 22, 2014, Neogen,s CEO commented about several new developments ... "It was my intent Tuesday at our conference call ... type of rodenticide, but certainly not to give any ...
(Date:7/24/2014)... July 24, 2014 1000 balances – ... input on customers’ weighing needs and expertly narrows down ... of balances, scales or even terminals. , First, ... smallest weight (or select readability instead) and define the ... additional selection criteria narrows down the list to models ...
Breaking Biology Technology:National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 33 angelMD Startups Make Livestrong Big C Semi-finals 2Neogen comments on SenesTech 2
... SAN DIEGO, May 9, 2011 Ardea Biosciences, Inc. ... on the development of small-molecule therapeutics for the treatment ... results for the first quarter ended March 31, 2011. ... lesinurad in combination with allopurinol demonstrate lesinurad,s potential to ...
... 9, 2011 Cell Biosciences, Inc. today announced the ... Patent and Trademark Office, Patent Nos. 7,935,489, 7,935,308 and ... Cell Biosciences, NanoPro™ Assay Technology. NanoPro assay systems utilize ... high-sensitivity measurement of specific proteins in complex biological samples. ...
... May 9, 2011 BD Diagnostics, a segment of ... (NYSE: BDX ), and Diagenode SA, an ... agreement to co-develop seven initial molecular diagnostic assays on ... enteric and central nervous system diseases.   ...
Cached Biology Technology:Ardea Biosciences Reports Recent Accomplishments and Announces First Quarter 2011 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces First Quarter 2011 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces First Quarter 2011 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces First Quarter 2011 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces First Quarter 2011 Financial Results 6BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System 2BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System 3BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System 4
(Date:7/24/2014)... has its own microbial terroir, meaning the microbial populations ... in the product, creating the final flavor according to ... Applied and Environmental Microbiology . This is the first ... sake brewery. , Many sake makers inoculate with ... Mills of the University of California, Davis, but he ...
(Date:7/24/2014)... Albert Einstein College of Medicine of Yeshiva ... Fox Foundation for Parkinson,s Research to translate a basic ... drug discovery project will test chemical compounds on a ... drug that acts on an underlying cause of the ... many people manage their symptoms, we are eager to ...
(Date:7/24/2014)... molecules, which have similar counterparts in humans, affect the ... nerve signals into the hippocampus, an area of the ... and the creation of memories. The results of the ... . , Brain function depends on the active communication ... neurons are woven together into a dense network where ...
Breaking Biology News(10 mins):The microbes make the sake brewery 2Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 2Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 3A protein couple controls flow of information into the brain's memory center 2A protein couple controls flow of information into the brain's memory center 3A protein couple controls flow of information into the brain's memory center 4
... of their brain that helps them appreciate the pain their ... of the brain connected with controlling emotions, according to new ... Because doctors sometimes have to inflict pain on their ... develop the ability to not be distracted by the suffering, ...
... acquired 12,000 new animalsmicroscopic Elkhorn coral larvae harvested ... of an international collaborative program to raise the ... day return the animals, once they are grown, ... Zoo Reproductive Scientist Dr. Mary Hagedorn and Invertebrates ...
... alAbsi, Ph.D., and a team of national collaborators have ... National Institutes of Health (NIH) for their research, AutoSense: ... alAbsi is a professor and founding director of Duluth ... SchoolDuluth Campus. , The project is among the first ...
Cached Biology News:Doctors learn to control their own brains' pain responses to better treat patients 2Doctors learn to control their own brains' pain responses to better treat patients 3Smithsonian scientists working to save microscopic threatened species 2Mustafa al'Absi Ph.D. and national team awarded major NIH grant 2
...
... cytostatic and anti-viral agent. Inhibits several important steps ... formation of HUVEC cells. Also reduces intracellular reactive ... IL-8 release of endothelial cells. ... 16 O 8 MolWeight: ...
... includes the pZErO-1 vector with Zeocin resistance ... vector utilizes positive selection to eliminate high ... resistance gene reduces the overall vector size ... kit contains all of the reagents you ...
NATIVE, ENZYME PORCINE TRYPSIN...
Biology Products: